Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature
Authors:
- Karen Davis‐BrunoKDKaren Davis‐Bruno
- Melissa S. TassinariMTMelissa S. Tassinari
- 15 June 2011
- journal article
- review article
- Published by Wiley in Birth Defects Research Part B: Developmental and Reproductive Toxicology
- Vol. 92 (3) , 240-250
Abstract
Docosahexanoic acid (DHA) and arachidonic acid (ARA) are long chain essential fatty acids used as supplements in commercial infant formula. DHA/ARA deficient states are associated with adverse neurological outcomes in animals and humans. Preterm infants are at risk for DHA/ARA deficiency. A few clinical reports on the effects of fatty acid supplementation have shown benefit in preterm, low birth weight, and normal infants in the first year of life, whereas others did not. Studies in animals have reported shortened gestation, fetal growth retardation, reduced infant body mass, and increased fetal mortality with consumption of fatty acids during pregnancy. To understand the data that support fatty acid supplementation in infant formula, a review of the animal model literature was undertaken, to examine the effects of DHA/ARA on neurodevelopment, including the effects on visual acuity. Several points emerged from this review. (1) Animal studies indicate that requirements for DHA/ARA vary depending on developmental age. Alterations of the ratio of DHA/ARA can impact developmental outcome. (2) The available studies suggest that while supplementation of DHA/ARA in an appropriate ratio can increase tissue levels of these fatty acids in the brain and retina, tissues sensitive to depletion of fatty acids, the benefit of routine supplementation remains unclear. Few studies measure functional outcome relative to changes in physiologic pools of DHA/ARA after supplementation. (3) Animal literature does not support a clear long‐term benefit of replenishing DHA/ARA tissue levels and administration of these fatty acids at concentrations above those in human milk suggests adverse effects on growth, survival, and neurodevelopment. Birth Defects Res (Part B) 92:240–250, 2011.Keywords
This publication has 35 references indexed in Scilit:
- Excess omega-3 fatty acid consumption by mothers during pregnancy and lactation caused shorter life span and abnormal ABRs in old adult offspringNeurotoxicology and Teratology, 2010
- Early determinants of development: a lipid perspectiveThe American Journal of Clinical Nutrition, 2009
- Docosahexaenoic acid supplementation in pregnancy and lactationThe American Journal of Clinical Nutrition, 2009
- Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathologyProstaglandins, Leukotrienes and Essential Fatty Acids, 2006
- HEALTH BENEFITS OF DOCOSAHEXAENOIC ACID (DHA)Pharmacological Research, 1999
- Sudden infant death syndrome: Effect of breast and formula feeding on frontal cortex and brainstem lipid compositionJournal of Paediatrics and Child Health, 1995
- At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby?Early Human Development, 1991
- Rhesus Monkey as a Model for Normal Vision of HumansOptometry and Vision Science, 1985
- Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys.Journal of Clinical Investigation, 1984
- Scotopic Spectral Sensitivity in the MonkeyScience, 1963